BioCardia, Inc.

BCDA

BioCardia, Inc.

BCDA

Insider Sentiment (TTM):

Last Purchase:2026-06-23Last Sale:2024-12-20Shares Purchased (TTM):803,400Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:666,251Shares Outstanding:10,812,419Institutional Ownership Pct.:6.16%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	4	1	2	5	1	1	2	5	1	1	1	2
Accounts Receivable Net Current	0	0	0	-	0	-	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	4	1	3	5	1	1	3	5	2	1	1	2
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	5	2	3	6	2	2	4	6	3	3	3	4
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	0	1	1	1	1	1
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	2	3	2	3	4	3	2	3	4	4	4	3
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Operating Lease Liability Noncurrent	0	0	0	0	0	0	1	1	1	1	1	1
Liabilities	2	3	3	4	4	4	3	4	5	5	5	4
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	175	170	169	169	163	161	161	161	154	152	151	149
Retained Earnings Accumulated Deficit	-172	-171	-168	-166	-165	-163	-160	-158	-156	-154	-152	-150
Stockholders Equity	3	-1	1	3	-2	-2	1	3	-2	-2	-2	-1
Liabilities And Stockholders Equity	5	2	3	6	2	2	4	6	3	3	3	4
Allowance For Doubtful Accounts Receivable Current	0	0	0	-	0	-	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	-
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	100	100	100	100
Common Stock Shares Issued	15	11	11	11	6	-	5	5	2	2	2	1
Shares Outstanding	15	11	11	11	6	5	5	5	2	2	2	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	1.98%	18.81%	-18.81%	-	-	-	-	-	-	-	-	-
2025	-21.66%	-23.47%	-23.10%	22.62%	-19.05%	-16.67%	5.38%	-2.31%	-5.38%	-2.48%	-16.53%	-27.27%
2024	-38.00%	-50.50%	-50.00%	-14.02%	3.79%	-9.47%	-9.79%	-1.70%	5.11%	-24.71%	-4.31%	-14.51%
2023	-	-	-	-	-	-	52.27%	50.00%	4.55%	-14.29%	-7.14%	-45.87%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.09	0.41	1.12	1.62	0.33	0.36	1.13	1.78	0.39	0.31	0.40	0.64
Quick Ratio	2.02	0.35	1.03	1.60	0.27	0.29	1.02	1.74	0.35	0.25	0.32	0.58
Working Capital	2.24M	-1.64M	300.00K	2.06M	-2.44M	-2.06M	301.00K	2.22M	-2.50M	-2.81M	-2.15M	-1.21M
Leverage & Debt
Debt to Equity	0.76	-2.61	2.81	1.34	-2.11	-2.43	3.45	1.28	-2.47	-2.18	-2.86	-6.68
Debt Ratio	0.43	1.62	0.74	0.57	1.90	1.70	0.78	0.56	1.68	1.85	1.54	1.18
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.09	0.10	0.07	0.09
Days Sales Outstanding TTM	-	-	-	-	-	-	-	293.03	53.30	82.28	101.01	129.35
Receivables Turnover TTM	0.00	0.00	0.00	-	0.00	-	-	1.25	6.85	4.44	3.61	2.82
Per Share Metrics
Diluted EPS TTM	-	-0.72	-	-	-1.74	-1.81	-	-	-	-	-	-
Free Cash Flow Per Share TTM	-0.63	-0.69	-1.12	-1.17	-1.64	-1.72	-2.88	-2.58	-3.79	-5.34	-7.07	-7.73
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-281,733.33%	-13,794.83%	-10,935.21%	-2,010.75%	-2,224.15%	-2,441.09%	-2,206.67%
Net Profit Margin TTM	-	-	-	-	-	-279,700.00%	-13,700.00%	-10,876.06%	-1,999.77%	-2,208.76%	-2,425.79%	-2,197.72%
Growth Metrics
Net Revenue Growth (1Y)	-	-100.00%	-100.00%	-100.00%	-100.00%	-99.36%	-87.84%	-87.54%	0.71%	-65.49%	-64.72%	-56.98%
Net Income Growth (1Y)	-16.55%	-7.34%	3.55%	10.59%	2.75%	-18.83%	-31.33%	-38.36%	-34.21%	-14.45%	-2.82%	1.52%
EPS Growth (1Y)	-65.08%	-60.27%	-57.38%	-50.19%	-61.88%	-70.66%	-64.66%	-68.58%	-52.37%	-31.29%	-18.65%	-16.15%
Valuation Metrics
P/E TTM	-2.04	-1.68	-1.01	-0.95	-1.12	-1.40	-0.75	-1.14	-0.65	-1.00	-1.21	-0.74
P/B TTM	5.55	-12.27	9.31	3.08	-5.23	-7.75	7.15	3.20	-2.84	-4.53	-8.72	-14.08
P/S TTM	-	-	-	-	-	3,924.95	103.13	124.25	13.03	22.02	29.31	16.31
Market Cap	15.00M	13.08M	8.33M	8.10M	9.87M	11.77M	5.98M	8.82M	5.57M	10.30M	13.98M	9.29M
Enterprise Value	10.88M	12.13M	5.84M	2.81M	8.89M	10.83M	3.61M	3.89M	4.15M	9.36M	12.88M	7.46M
Calculated Values
Free Cash Flow TTM	-7.57M	-7.49M	-7.44M	-7.37M	-8.32M	-7.98M	-7.89M	-7.31M	-7.11M	-8.95M	-9.99M	-11.13M
Net Debt	-4.12M	-951.00K	-2.50M	-5.29M	-980.00K	-949.00K	-2.37M	-4.93M	-1.42M	-949.00K	-1.10M	-1.84M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-23Purchase

Owner: Stertzer, Simon H

Title: -

Shares: 39,000

Price/Share: $1.00

Value: $39,000.00

Shares Owned: 166,338

Relationship: Director

Ownership: Direct

2026-06-18Purchase

Owner: Altman, Peter

Title: President and CEO

Shares: 800

Price/Share: $0.96

Value: $768.00

Shares Owned: 300,566

Relationship: Director,Officer

Ownership: Direct

2026-06-09Purchase

Owner: Altman, Peter

Title: President and CEO

Shares: 5,000

Price/Share: $0.85

Value: $4,250.00

Shares Owned: 298,266

Relationship: Director,Officer

Ownership: Direct

2026-05-20Purchase

Owner: Altman, Peter

Title: President and CEO

Shares: 1,500

Price/Share: $0.92

Value: $1,380.00

Shares Owned: 293,266

Relationship: Director,Officer

Ownership: Direct

2026-05-18Purchase

Owner: Altman, Peter

Title: President and CEO

Shares: 5,700

Price/Share: $0.92

Value: $5,244.00

Shares Owned: 291,566

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-23	Stertzer, Simon H	Director	-	Direct	Purchase	39,000	1.00	$39,000.00	166,338	4
2026-06-18	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	800	0.96	$768.00	300,566	4
2026-06-09	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	5,000	0.85	$4,250.00	298,266	4
2026-05-20	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	1,500	0.92	$1,380.00	293,266	4
2026-05-18	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	5,700	0.92	$5,244.00	291,566	4
2026-05-15	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	5,100	1.02	$5,202.00	285,866	4
2026-04-29	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	5,000	1.11	$5,550.00	280,766	4
2026-04-21	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	400	1.23	$492.00	275,766	4
2026-03-25	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	300	1.22	$366.00	274,766	4
2026-02-04	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	5,000	1.13	$5,650.00	273,866	4
2026-01-21	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	300	1.34	$402.00	268,866	4
2025-12-17	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	900	1.30	$1,170.00	267,966	4
2025-09-19	Blank, Andrew Scott	Director	-	Indirect	Purchase	288,000	1.25	$360,000.00	634,023	4
2025-09-19	Stertzer, Simon H	Director	-	Indirect	Purchase	398,400	1.25	$498,000.00	591,054	4
2025-09-19	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	48,000	1.25	$60,000.00	216,762	4
2025-08-22	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	700	1.83	$1,281.00	168,762	4
2025-08-13	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	100	1.83	$183.00	168,062	4
2025-08-12	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	400	1.75	$700.00	167,962	4
2025-08-11	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	1,700	1.76	$2,992.00	167,562	4
2025-06-30	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	24,096	2.08	$50,119.68	165,862	4
2025-06-30	Blank, Andrew Scott	Director	-	Indirect	Purchase	72,289	2.08	$150,361.12	346,023	4
2025-06-30	Stertzer, Simon H	Director	-	Indirect	Purchase	72,289	2.08	$150,361.12	192,654	4
2025-06-30	Mcclung, David	Officer	Chief Financial Officer	Direct	Purchase	4,819	2.08	$10,023.52	47,950	4
2025-05-30	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	100	2.21	$221.00	141,766	4
2025-05-22	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	700	1.89	$1,323.00	141,666	4
2025-05-16	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	300	2.43	$729.00	139,366	4
2025-04-23	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	26,246	1.91	$50,129.86	138,966	4
2025-04-23	Mcclung, David	Officer	Chief Financial Officer	Direct	Purchase	13,123	1.91	$25,064.93	43,131	4
2025-04-23	Krasno, Richard M	Director	-	Direct	Purchase	13,123	1.91	$25,064.93	16,268	4
2025-04-23	Stertzer, Simon H	Director	-	Indirect	Purchase	104,986	1.91	$200,523.26	120,365	4
2025-04-23	Blank, Andrew Scott	Director	-	Indirect	Purchase	131,233	1.91	$250,655.03	265,957	4
2025-04-23	Facteau, Bill	Director	-	Direct	Purchase	13,123	1.91	$25,064.93	13,123	4
2025-04-15	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	100	2.14	$214.00	112,720	4
2025-04-11	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	300	2.03	$609.00	112,620	4
2025-04-07	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	500	1.96	$980.00	112,020	4
2025-04-04	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	800	2.04	$1,632.00	111,520	4
2025-04-03	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	600	2.20	$1,320.00	110,720	4
2025-03-05	Stertzer, Simon H	Director	-	Direct	Purchase	1,000	2.45	$2,450.00	57,138	4
2025-03-04	Stertzer, Simon H	Director	-	Direct	Purchase	15,536	2.30	$35,732.80	56,138	4
2025-03-03	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	500	2.11	$1,055.00	108,420	4
2025-02-07	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	600	2.48	$1,488.00	107,920	4
2025-01-30	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	239	2.38	$568.82	107,320	4
2024-12-23	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	1,000	2.06	$2,060.00	106,581	4
2024-12-20	Gillis, Edward M	Officer	Senior Vice President, Devices	Direct	Sale	3,257	2.00	$6,514.00	8,968	4
2024-12-05	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	250	2.22	$555.00	105,581	4
2024-11-15	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	1,350	1.87	$2,524.50	105,331	4
2024-07-01	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	300	3.05	$915.00	39,745	4
2024-06-21	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	500	3.29	$1,645.00	39,245	4
2024-06-14	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	500	3.52	$1,760.00	38,745	4
2024-06-10	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	1,000	3.36	$3,360.00	38,245	4
2024-04-19	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	2,750	0.37	$1,017.50	558,697	4
2024-03-28	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	500	0.39	$195.00	555,947	4
2024-02-13	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	108,108	0.46	$49,729.68	555,447	4
2024-01-19	Frost, Phillip Md Et Al, …	TenPercentOwner	-	Indirect	Sale	129,802	0.43	$55,814.86	1,896,025	4
2023-08-17	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	4,000	0.87	$3,480.00	447,339	4/A
2023-08-14	Altman, Peter	Director,Officer	President and CEO	Direct	Purchase	4,500	0.88	$3,960.00	443,339	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.16%

Inst. Shares: 666,251

Shares Outstanding: 10,812,419

2025-12-31

9.57%

Inst. Shares: 638,323

Shares Outstanding: 6,666,943

2025-09-30

6.51%

Inst. Shares: 408,829

Shares Outstanding: 6,277,848

2025-06-30

5.66%

Inst. Shares: 286,279

Shares Outstanding: 5,059,736

2025-03-31

4.96%

Inst. Shares: 229,846

Shares Outstanding: 4,635,764

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	666,251	10,812,419	6.16%
2025-12-31	638,323	6,666,943	9.57%
2025-09-30	408,829	6,277,848	6.51%
2025-06-30	286,279	5,059,736	5.66%
2025-03-31	229,846	4,635,764	4.96%
2024-12-31	124,849	2,743,828	4.55%
2024-09-30	101,482	2,827,492	3.59%
2024-06-30	75,419	1,877,069	4.02%
2024-03-31	1,879,258	1,675,539	112.16%
2023-12-31	1,868,556	1,411,998	132.33%
2023-09-30	1,607,468	1,441,043	111.55%
2023-06-30	1,222,685	1,358,968	89.97%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

BioCardia, Inc. (BCDA) — SEC Financial Statements & Analysis

BioCardia, Inc. (BCDA) is a biological products, (no diagnostic substances) company, incorporated in DE. BioCardia, Inc. trades on Nasdaq as: BCDA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BioCardia, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.76x, a Price-to-Sales (P/S) ratio of 3924.95x (TTM), a Price-to-Book (P/B) ratio of 5.55x (TTM), at a market cap of $15.00M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.76x
P/S TTM: 3924.95x
P/B TTM: 5.55x
Market Cap: $15.00M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BioCardia, Inc. in?

BioCardia, Inc. (BCDA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is BCDA's market cap?

BioCardia, Inc. (BCDA) has a market capitalization of $15.00M as of 2026-06-30.

What exchange does BCDA trade on?

BioCardia, Inc. (BCDA) trades on the Nasdaq.

Where is BioCardia, Inc. incorporated?

BioCardia, Inc. is incorporated in DE.

BioCardia, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

BioCardia, Inc. (BCDA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

BioCardia, Inc. (BCDA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.